MedTrace Logo

Assessment of Medherent Medication Management Device and Adherence Platform

NCT03775044 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-10-24

No results posted yet for this study

Summary

This study uses a stepped wedge designs to estimate the effect of using the Medherent Medication Management Device on medication adherence for a population of 150 individuals who are diagnosed with serious mental illness.

Conditions

  • Mental Health Disorder
  • Medication Adherence

Interventions

DEVICE

Medherent Device

The Medherent Medication Management Device (MMD) is intended to enable patients to self-manage their medication at home when it may otherwise require assistance.

Sponsors & Collaborators

  • University of Maryland

    collaborator OTHER

  • Terrapin Pharmacy

    lead INDUSTRY

Principal Investigators

  • Joel Feldman, JD · Terrapin Pharmacy

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2022-03-31
Completion
2023-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03775044 on ClinicalTrials.gov